About Curavit Clinical Research
Curavit Clinical Research is a private company based in Scarsdale, New York, incorporated in 2019 in Delaware. It has reported $11,426,701 raised in one offering on Form D since October 2022. Its chief executive is Joel Morse.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| Sep 28, 2022 | Oct 13, 2022amended Sep 5, 2024 | $11,426,701of $11.6M target | 30 | $380K | Equity, Options, Securities on exerciseRule 506(b) | Form D/A ↗2 earlier filings |
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on Curavit Clinical Research's Form D filed Sep 5, 2024.
JK
Jackie Kent
Director
RL
Rich Lester
Director
JM
Joel Morse
Chief Executive Officer and director
NL
Nathanael Lentz
Director
DH
David Hanaman
Director